Capital International Investors Pfizer Inc Transaction History

Capital International Investors

$475 Billion
Q2 2024

A detailed history of Capital International Investors transactions in Pfizer Inc stock. As of the latest transaction made, Capital International Investors holds 1,522,786 shares of PFE stock, worth $44.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,522,786

Previous 2,755,411 44.73%

Holding current value

$44.3 Million

Previous $76.5 Million 44.28%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $31.1 Million - $36.5 Million	-1,232,625 Reduced 44.73%	1,522,786 $42.6 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $234 Million - $268 Million	-9,021,919 Reduced 76.6%	2,755,411 $76.5 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $135 Million - $175 Million	-5,160,926 Reduced 30.47%	11,777,330 $339 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $376 Million - $439 Million	-11,706,423 Reduced 40.87%	16,938,256 $562 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $988 Million - $1.14 Billion	-27,358,256 Reduced 48.85%	28,644,679 $1.05 Billion
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $90.7 Million - $118 Million	-2,302,688 Reduced 3.95%	56,002,935 $2.28 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $124 Million - $163 Million	2,981,745 Added 5.39%	58,305,623 $2.99 Billion
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $258 Million - $315 Million	5,892,896 Added 11.92%	55,323,878 $2.42 Billion
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $507 Million - $601 Million	10,900,979 Added 28.29%	49,430,982 $2.59 Billion
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $1.71 Billion - $2.12 Billion	37,310,556 Added 3059.63%	38,530,003 $1.99 Billion
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $26,031 - $38,587	-630 Reduced 0.05%	1,219,447 $72 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $22,922 - $29,445	584 Added 0.05%	1,220,077 $52.5 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $147 Million - $166 Million	-4,389,239 Reduced 78.26%	1,219,493 $44.2 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $140,306 - $178,411	4,192 Added 0.07%	5,608,732 $206 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $24.3 Million - $28.5 Million	-765,867 Reduced 12.02%	5,604,540 $206 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $55.9 Million - $67.8 Million	-1,854,583 Reduced 22.55%	6,370,407 $208 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $373 Million - $532 Million	-13,783,242 Reduced 62.63%	8,224,990 $268 Million
Q4 2019 Feb 18, 2020	SELL	$32.92 - $37.36 $334 Million - $379 Million	-10,139,570 Reduced 31.54%	22,008,232 $862 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $12.4 Million - $16.1 Million	381,652 Added 1.2%	32,147,802 $1.16 Billion
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $7.51 Million - $8.43 Million	203,129 Added 0.64%	31,766,150 $1.38 Billion
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $42.3 Million - $46.5 Million	1,127,991 Added 3.71%	31,563,021 $1.34 Billion
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $46.4 Million - $52.9 Million	-1,206,619 Reduced 3.81%	30,435,030 $1.33 Billion
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $2.56 Million - $3.1 Million	74,225 Added 0.24%	31,641,649 $1.39 Billion
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $33.6 Million - $35.9 Million	1,019,773 Added 3.34%	31,567,424 $1.15 Billion
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $83.4 Million - $96.7 Million	2,613,150 Added 9.35%	30,547,651 $1.08 Billion
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $135 Million - $143 Million	-4,051,500 Reduced 12.67%	27,934,501 $1.01 Billion
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $992 Million - $1.09 Billion	31,986,001	31,986,001 $1.14 Billion

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Pfizer Inc Transaction History